Treating allergic diseases with humanized anti-CD40L antibody
US7074406B2 · kind B2 · utility
11Cited by
7References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2002 |
| Grant date | Jul 11, 2006 |
| Priority date | — |
| Expiry date | Mar 20, 2024 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to humanized antibodies which bind human gp39 and their use as therapeutic agents. These humanized antibodies are especially useful for treatment of autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.